190 likes | 385 Views
Dosage Regimen Design for Patients with Renal Insufficiency. Pharmacy 732 Winter, 2001. Parameter Adjustment or “Q” Factor: Concept. How much?. Q Factor: Where’s It Come From?. Assuming nonrenal Cl is not changed by RF:. Eq. 1. Q Factor: Where...?. But. Eq. 2. Q Factor: Where…?.
E N D
Dosage Regimen Designfor Patients with Renal Insufficiency Pharmacy 732 Winter, 2001
Q Factor: Where’s It Come From? Assuming nonrenal Cl is not changed by RF: Eq. 1
Q Factor: Where...? But Eq. 2
Q Factor: Where…? Since ClR-N=feClT-N Eq. 3
Q Factor: Where…? Eq. 1 Eq. 2 Eq. 3
Q Factor: Assumptions • Know fe (normal renal function) • ClR GFR (i.e. CrCl) • No change in ClNR • First-order kinetics • One compartment model • Metabolites not active/toxic
Q Factor: What Do You Do With It? • Adjust dosage regimen (D, , or both) • Adjusting D alone • DRF = DN Q • Css similar, peak lower, trough higher • Adjusting alone • RF = N / Q • Css similar, peak similar, trough similar
Q Factor: What Do You…? • Adjust both D and • DRF = DN Q RF/ N • Css similar, peak and trough in-between
An Example: Ganciclovir Antiviral, normal dose = 5 mg/kg, dose interval = 12 hrs. Need to dose drug in patient with CrCl = 10 mL/min. What is Q factor?
WARNING! • Other kinetic parameters may also be altered by RF • Absorption • Distribution (, , ) • Metabolism (, , ) • Always best to have literature for specific drug in renal failure patients • Chapter 47 of DiPiro
Other Sources of Information • Package insert • Drug Information Handbook • AHFS Drug Information • Bennett